Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC-Reference-Cited by-同舟云学术

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC

Published:2020-07-17 Issue:1 Volume:70 Page:189-202
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bao Xuanwen^ORCID,Shi Run,Zhao Tianyu,Wang Yanfang,Anastasov Natasa,Rosemann Michael,Fang Weijia^ORCID

Funder

China Scholarship Council

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02669-7.pdf

Reference41 articles.

1. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938–1948

2. Chung W, Eum HH, Lee H-O, Lee K-M, Lee H-B, Kim K-T et al (2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun 8(1):1–12

3. Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y et al (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486(7403):395–399

4. Karaayvaz M, Cristea S, Gillespie SM, Patel AP, Mylvaganam R, Luo CC et al (2018) Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq. Nat Commun 9(1):1–10

5. Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA et al (2008) Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26(8):1275–1281

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer;IET Systems Biology;2024-08-13

2. M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1;Pathology - Research and Practice;2024-08

3. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls;Clinical and Experimental Medicine;2024-07-13

4. Application of machine learning for high-throughput tumor marker screening;Life Sciences;2024-07

5. YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer;iScience;2024-06